BMC Medical Genomics

Cell-Based therapeutics in human disease

Guest Edited by Yan Ma, Mohd Hussain Shah and Meijie Tian

Long-read sequencing technologies for medical diagnostics

Guest Edited by Laia Bassaganyas

Mechanistic insight into health and disease using spatial transcriptomics

Guest Edited by Zixuan Cang

Genomics of underrepresented populations

Guest Edited by Sally N. Adebamowo, Hoh Boon-Peng, Mohit Divakar, and Kumarasamy Thangaraj

Multi-omics in metabolic diseases

Guest Edited by Isabella Zanella       
 

Genomics of cardiovascular diseases

Guest Edited by Zhe Wang and Chen Yao 

Antimicrobial resistance (AMR)

Guest Edited by Zhi Ruan

  Review: Whole genome sequencing in clinical practice

Blood-based DNA methylation and exposure risk scores predict PTSD with high accuracy in military and civilian cohorts

Shared etiology of Mendelian and complex disease supports drug discovery

Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs

A brief comparison of polygenic risk scores and Mendelian randomisation

Mendelian randomisation and polygenic risk score analysis have become increasingly popular in the last decade due to the advent of large-scale genome-wide association studies. Each approach has valuable applications, some of which are overlapping, yet there are important differences which we describe here.